Products in Development
Schedule III formulations built for medicinal intent
ThrivePath is developing a line of precision-formulated medicinal products under Schedule III compliance. Every format is designed around bioavailability, consistent dosing, and patient experience. Available under the ThrivePath brand and through white-label and R&D partnerships.
Partnership Programs
Three ways to work with us
ThrivePath products are available under our own brand and through two structured partnership programs for qualified operators, dispensaries, and research institutions.
ThrivePath Brand
Our own label. Sold through our licensed Long Beach dispensary to qualified medicinal patients. Each product developed and quality-controlled in-house, formulated with intention.
White Label
Qualified cannabis operators and dispensaries can access ThrivePath formulations under their own brand. We handle formulation, compliance, and consistency. You bring the patient relationship.
R&D Licensing
Universities, clinical researchers, and healthcare institutions conducting Schedule III cannabis research can partner with ThrivePath for standardized, compliant cannabinoid formulations tailored to study protocols.
Inquire About Partnership
All programs are subject to licensure verification. Formulations are tailored to each partner, whether patient-facing, research-grade, or retail.
Get in TouchAll products are subject to DCC licensing requirements and applicable Schedule III federal regulations. White label and R&D programs require verified licensure. Nothing here constitutes a commercial offer.